References
- Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229–233
- Grunze H, Dobmeier M. 2002. Modul Therapie akuter Episoden. In: Deutsche Gesellschaft für Bipolare Störungen e.V. (DGBS e.V.). Weissbuch Bipolare Störungen in Deutschland. Hamburg: CP Verlag. p 57–66.
- Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53–59
- Hirschfeld RM, Keck PE, Jr, Kramer M, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004; 161: 1057–1065
- Kalkman HO, Loetscher E. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur J Pharmacol 2003; 462: 33–40
- Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. Risperidone in the treatment of acute mania: a double-blind, placebo-controlled study of 290 patients. Br J Psychiatry 2005; 187: 229–234
- Leysen JE, Janssen PM, Megens AA, Schotte A. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 1994; 55(Suppl 5)5–12
- Licht RW, Gouliaev G, Vestergaard P, Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264–267
- Müller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002; 359: 241–247
- Nguyen LN, Guthrie SK. Risperidone treatment of bipolar mania. Ann Pharmacother 2006; 40: 674–682
- Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146–1154
- Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 2005; 15: 75–84
- Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159–171
- Suzuki E, Obata M, Yoshida Y, Miyaoka H. Tardive dyskinesia with risperidone and anticholinergics. Am J Psychiatry 2002; 159: 1948
- Wolfsperger M, Greil W, Rossler W, Grohmann R. 2006. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord in press.
- Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435